Original Articles

Grain-sized moxibustion attenuates renal dysfunction and inflammation in naturally aging mice via the phosphatidylinositol 3-kinase/protein kinase B/nuclear factor-κB pathway

  • XU Hui ,
  • QI Li ,
  • QIAN Yutong ,
  • LIU Chang ,
  • LI Zhenchen ,
  • MENG Qi ,
  • LIU Shimin ,
  • JIAO Danli ,
  • ZHAO Chen
Expand
  • 1 School of Acupuncture-moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    2 Department of TCM, Taizhou Second People's Hospital, Taizhou 225500, China
    3 Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Prof. ZHAO Chen, School of Acupuncture-moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. ztzhaochen@126.com,Telephone: +86-13764276086;
Prof. JIAO Danli, School of Acupuncture-moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. 937095417@qq.com,Telephone: +86-18616124659

Received date: 2025-05-29

  Accepted date: 2025-11-05

  Online published: 2026-10-09

Supported by

Three-year Action Plan of the National Health and Family Planning Commission: Study on the Effect and Mechanism of Acupuncture and Moxibustion in Regulating Senescence-associated Secretory Phenotype to Alleviate Renal Fibrosis via Wnt family Member 9a /β-catenin Signaling Pathway(E2-ED19005);the Budget for the Project of Shanghai University of Traditional Chinese Medicine: Clinical Study of Eight-Shu Moxibustion in the Treatment of Early Diabetic Nephropathy(2021LK027);the Project of Clinical Research of the Health Industry of the Shanghai Municipal Health Commission(202340167)

Abstract

OBJECTIVE: To investigate the potential mechanisms by which Zusanli (ST36) moxibustion alleviates age-related renal lesions viaregulating inflammation.

METHODS: Male mice were divided into three groups: the young group (adult mice aged 3 months), the old group (21-month-old mice maintained until 24 months), and the grain-sized moxibustion (GS-Moxi) group [21-month-old mice treated with grain-sized moxibustion (GS-Moxi) at Zusanli (ST36) for 3 months]. To assess the protective effects of GS-Moxi on age-related renal injury, serum creatinine, blood urea nitrogen levels, and renal tissue were analyzed using periodic acid-Schiff and Masson’s trichrome staining. RNA sequencing (RNA-seq) was conducted for gene set enrichment analysis (GSEA) and kyoto encyclopedia of genes and genomes (KEGG) pathway analysis. Additionally, Western blotting and immunohistochemistry (IHC) were employed to examine the involvement of the phosphatidylinositol 3-kinase/ protein kinase B/nuclear factor-κB (PI3K/AKT/NF-κB) signaling pathway in response to GS-Moxi treatment.

RESULTS: Our findings demonstrated that GS-Moxi significantly improved renal histopathological features and ameliorated age-related renal dysfunction. Additionally, GS-Moxi attenuated the upregulation of fibrosis markers, senescence markers [p16, p21, and senescence-associated β-galactosidase (SA-β-gal)], oxidative stress markers (superoxide dismutase (SOD) and malondialdehyde (MDA)), and inflammatory cytokines [tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β)] in the aging kidneys. Transcriptomic analysis, followed by GSEA and KEGG pathway enrichment, revealed the PI3K/Akt signaling pathway as a critical regulatory pathway. Western blotting and IHC further confirmed that GS-Moxi modulates the PI3K/AKT/NF-κB signaling pathway in the aging kidney.

CONCLUSIONS: Our study confirmed that GS-Moxi at ST36 has a significant therapeutic effect on age-related renal injury by inhibiting the PI3K/AKT/NF-κB signaling pathway, thereby reducing the release of inflammatory factors and mitigating oxidative stress injury.

Cite this article

XU Hui , QI Li , QIAN Yutong , LIU Chang , LI Zhenchen , MENG Qi , LIU Shimin , JIAO Danli , ZHAO Chen . Grain-sized moxibustion attenuates renal dysfunction and inflammation in naturally aging mice via the phosphatidylinositol 3-kinase/protein kinase B/nuclear factor-κB pathway[J]. Journal of Traditional Chinese Medicine, 2026 , 46(5) : 1117 -1126 . DOI: 10.19852/j.cnki.jtcm.2026.05.006

References

[1] Zelniker TA, Wiviott SD, Raz I, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and Meta-analysis of cardiovascular outcome trials. Lancet 2019; 39310166: 31-9.
[2] Yang M, Liu Y, Luo SL, et al. DsbA-L ameliorates renal aging and renal fibrosis by maintaining mitochondrial homeostasis. Acta Pharmacol Sin 2024; 454: 777-89.
[3] Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol 2020; 165: 269-88.
[4] Tanriover C, Copur S, Mutlu A, et al. Early aging and premature vascular aging in chronic kidney disease. Clin Kidney J 2023; 1611: 1751-65.
[5] Jankowski J, Floege J, Fliser D, et al. Cardiovascular disease in chronic kidney disease pathophysiological insights and therapeutic options. Circulation 2021; 14311: 1157-72.
[6] Wang J, Wong Y-K, Liao F. What has Traditional Chinese Medicine delivered for modern medicine? Expert Rev Mol Med 2018; 20: e4.
[7] Wang ZQ, Xu MW, Shi Z, et al. Mild moxibustion for irritable bowel syndrome with diarrhea (IBS-D): a randomized controlled trial. J Ethnopharmacol 2022; 289: 115064.
[8] Yang XT, Wang WQ, Zhang Y, Wang JT, Huang FJ. Moxibustion improves ovary function by suppressing apoptosis events and upregulating antioxidant defenses in natural aging ovary. Life Sci 2019; 229: 166-72.
[9] Ouyang X, Duan H, Jin Q, et al. Moxibustion may delay the aging process of wistar rats by regulating intestinal microbiota. Biomed Pharmacother 2022; 146: 112147.
[10] Lu G, Li HX, Song ZW, et al. Combination of bone marrow mesenchymal stem cells and moxibustion restores cyclophosphamide-induced premature ovarian insufficiency by improving mitochondrial function and regulating mitophagy. Stem Cell Res Ther 2024; 151: 102.
[11] Sun H, Qiu MY, Li BQ, et al. Effect of moxibustion on quality of life in hemodialysis patients. Zhong Guo Zhen Jiu 2008; 285: 321-4.
[12] Li N, Qiu MY, Hao JR, et al. Randomized controlled trail on moxibustion for maintenance hemodialysis patients in deficiency syndrome. Zhong Guo Zhen Jiu 2011; 311: 15-8.
[13] Zhao SY, Liu WB, Wu HG, et al. Protective effect of mild moxibustion at zusanli on kidney and effect on FN and TGF-β1 expression in naturally aging rats. Shi Jie Zhong Yi Yao 2022; 1712: 1719-24.
[14] Jiao ZH, Gu Y, LI LN, et al. Liang regulation effect of moxibustion with small moxa-cone about the size of a wheat grain at “Zusanli” point on cellular immune function in elderly bedridden patients. Zhong Guo Zhong Yi Yao Ke Xue Ji Shu 2020; 271: 59-60.
[15] Hu D, Shen W, Gong C, et al. Grain-sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non-small cell lung cancer. J Cell Mol Med 2021; 256: 2900-8.
[16] Nie RR, Huang CH, Fu WB. Observation of therapeutic effect on post stroke depression treated by differentiation of spleen and stomach. Zhong Guo Zhen Jiu 2011; 314: 325-8.
[17] Liu J, Liu J, Wang XS, et al. Comparative study of different dosages of grain-sized moxibustion on uterine artery blood flow in patients with cold and dampness primary dysmenorrhea. Zhen Ci Yan Jiu 2024; 497: 760-6.
[18] Jiang Z, Zhou X, Li R, et al. Whole transcriptome analysis with sequencing: methods, challenges and potential solutions. Cell Mol Life Sci 2015; 7218: 3425-39.
[19] Zhao W, Li J, Li Y, et al. Preventive effect of collagen peptides from on acute kidney injury through attenuation of oxidative stress and inflammation. Oxid Med Cell Longev 2022; 2022: 8186838.
[20] Wang MX, Wang MM, Liu C, et al. A geniposide-phospholipid complex ameliorates posthyperuricemia chronic kidney disease induced by inflammatory reactions and oxidative stress. Eur J Pharmacol 2022; 930: 175157.
[21] Li J, Zhang K, Xu M, et al. Baicalin - 2- ethoxyethyl ester alleviates renal fibrosis by inhibiting PI3K/AKT/NF-kappa B signaling pathway. Toxicol Appl Pharmacol 2024; 483: 116827.
[22] LoRusso PM. Inhibition of the PI3K/AKT/mTOR pathway in solid tumors. J Clin Oncol 2016; 3431: 3803-15.
[23] Song Z, Zhu M, Wu J, et al. Fucoidans from cucumaria frondosa ameliorate renal interstitial fibrosis via inhibition of the PI3K/Akt/NF-kappa B signaling pathway. Food Funct 2022; 133: 1168-79.
[24] Zhang N, Li Z, Mu W, et al. Calorie restriction-induced SIRT6 activation delays aging by suppressing NF-kappa B signaling. Cell Cycle 2016; 157: 1009-18.
[25] Xu L, Wang J, Yu H, et al. GLIS1 alleviates cell senescence and renal fibrosis through PGC1-alpha mediated mitochondrial quality control in kidney aging. Free Radic Biol Med 2023; 209Pt 1: 171-84.
[26] Miao J, Liu J, Niu J, et al. Wnt/beta-catenin/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction. Aging Cell 2019; 185: e13004.
[27] Kim H, Yu MR, Lee H, et al. Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells. Aging Cell 2021; 202: e13317.
[28] Fang Y, Gong AY, Haller ST, et al. The ageing kidney: molecular mechanisms and clinical implications. Ageing Res Rev 2020; 63: 101151.
[29] Guo X, Xin Q, Wei P, et al. Antioxidant and anti-aging activities of longan crude and purified polysaccharide (LP-A) in nematode caenorhabditis elegans. Int J Biol Macromol 2024; 267Pt 2: 131634.
[30] Rahman MA, Shuvo AA, Bepari AK, et al. Curcumin improves D-galactose and normal-aging associated memory impairment in mice: in vivo and in silico-based studies. PLoS One 2022; 176: e0270123.
[31] Castel P, Ellis H, Bago R, et al. PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3Kalpha inhibition. Cancer Cell 2016; 302: 229-42.
[32] Dattilo V, D'Antona L, Talarico C, et al. SGK 1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation. Sci Rep 2017; 7: 45361.
[33] Abbruzzese C, Mattarocci S, Pizzuti L, et al. Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas. J Exp Clin Cancer Res 2012; 311: 4.
[34] Spagnuolo R, Dattilo V, D'Antona L, et al. Deregulation of SGK1 in ulcerative colitis: a paradoxical relationship between immune cells and colonic epithelial cells. Inflamm Bowel Dis 2018; 249: 1967-77.
[35] Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opin Investig Drugs 2013; 226: 701-14.
[36] Zhuang L, Jin G, Hu X, et al. The inhibition of SGK1 suppresses epithelial-mesenchymal transition and promotes renal tubular epithelial cell autophagy in diabetic nephropathy. Am J Transl Res 2019; 118: 4946-56.
[37] Wang J, Zhu H, Huang L, et al. Nrf2 signaling attenuates epithelial-to-mesenchymal transition and renal interstitial fibrosis via PI3K/Akt signaling pathways. Exp Mol Pathol 2019; 111: 104296.
[38] Wang Z, Chen Z, Li B, et al. Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-small ka, CyrillicB and PI3K/AKT signalling pathways. Pharm Biol 2020; 581: 828-37.
[39] Li D, Yu K, Feng F, et al. Hydroxychloroquine alleviates renal interstitial fibrosis by inhibiting the PI3K/Akt signaling pathway. Biochem Biophys Res Commun 2022; 610: 154-61.
[40] Jung KJ, Min KJ, Park JW, et al. Carnosic acid attenuates unilateral ureteral obstruction-induced kidney fibrosis via inhibition of Akt-mediated Nox4 expression. Free Radic Biol Med 2016; 97: 50-7.
[41] Dou F, Liu Y, Liu L, et al. Aloe-Emodin ameliorates renal fibrosis via inhibiting PI3K/Akt/mTOR signaling pathway in vivo and in vitro. Rejuvenation Res 2019; 223: 218-29.
[42] Zhu JF, Huang W, Yi HM, et al. Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation. Cell Death Dis 2018; 912: 1154.
[43] Liang F, Ren C, Wang J, et al. The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy. Oncogenesis 2019; 810: 59.
[44] Xu WT, Yang Z, Lu NH. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr 2015; 94: 317-24.
[45] White S, Lin L, Hu KB. NF-kappaB and tPA Signaling in kidney and other diseases. Cells 2020; 9: 1348.
Outlines

/

〈 〉